Actinium Pharmaceuticals, Inc. (ATNM) Earnings
|
Expand Research on ATNM
| Next EPS Date | 5/13/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -47.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/13/24 | Q124 | N/A | $0.02 | N/A | N/A | $11.67M | N/A | N/A | N/A | ||
| 3/15/24 | Q423 | N/A | -$0.58 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/30/23 | Q323 | N/A | -$0.51 | N/A | N/A | $460K | N/A | N/A | N/A | ||
| 11/6/23 | Q323 | N/A | -$0.53 | N/A | N/A | $575K | N/A | N/A | N/A | ||
| 10/27/23 | Q323 | N/A | -$0.54 | N/A | N/A | $460K | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.53 | N/A | N/A | $575K | N/A | N/A | N/A | ||
| 11/27/23 | Q323 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/20/23 | Q323 | N/A | -$0.53 | N/A | N/A | $575K | N/A | N/A | N/A |
